A recent systematic review and meta-analysis examined prediction models designed to forecast postoperative atrial fibrillation in patients who have undergone surgery for lung cancer. The researchers combined data from six different studies to evaluate how well these models work. They focused on the discriminative performance, which is often measured by the area under the curve, or AUC. The pooled AUC across all studies was 0.79, with individual study values ranging from 0.72 to 0.89. This suggests the models have some ability to distinguish between patients who will and will not develop the condition. However, the analysis revealed substantial heterogeneity between the studies, with an I2 value of 98.7%. This indicates that the results varied greatly depending on the specific study. The authors noted a high overall risk of bias and methodological weaknesses in the included research. These factors, along with a lack of external validation, restrict the clinical applicability of the findings. Readers should be cautious about relying on these models for individual patient decisions without further validation.
Prediction models for postoperative atrial fibrillation show mixed results in lung cancer patients
Photo by Joachim Schnürle / Unsplash
What this means for you:
Prediction models for postoperative atrial fibrillation show moderate accuracy but high variability in lung cancer patients. More on Cancer
Follicular T cell subsets and tertiary lymphoid structures may guide immunotherapy in ovarian cancer New immune targets offer hope for ovarian cancer patients
Frontiers · Jun 2, 2026
Tertiary lymphoid structures represent a promising but context-dependent biomarker and potential therapeutic intermediate in breast cancer Tertiary lymphoid structures may help predict breast cancer outcomes but need clearer definitions
Frontiers · Jun 2, 2026
Adding docetaxel to ADT and RT cuts mortality in high-risk prostate cancer with normal testosterone Adding chemo to hormone therapy for prostate cancer may depend on testosterone levels
· Jun 2, 2026
Favorable adiposity, statins, vitamin D, dried fruit linked to lower ovarian cancer risk in MR meta-analysis Genetic study links vitamin D, statins to lower ovarian cancer risk
· Jun 2, 2026